Literature DB >> 21858834

Local and intralesional therapy of in-transit melanoma metastases.

Alessandro Testori1, Mark B Faries, John F Thompson, E Pennacchioli, Jan P Deroose, Albertus N van Geel, Cornelis Verhoef, Francesco Verrecchia, Javier Soteldo.   

Abstract

Regional relapse of melanoma may occur as satellite or in-transit metastases proximal to the primary tumor in the direction of the lymph flow. The management of in-transit metastases is challenging because the efficacy of treatment is largely dictated by the biological behavior of the patient's melanoma. This review examines local treatment modalities.
Copyright © 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21858834     DOI: 10.1002/jso.22029

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

Review 1.  Current treatment of locoregional recurrence of melanoma.

Authors:  Malcolm Hart Squires; Keith A Delman
Journal:  Curr Oncol Rep       Date:  2013-10       Impact factor: 5.075

Review 2.  Subcutaneous metastases from melanoma: a discussion of clinical experience.

Authors:  Piotr Rutkowski; Marcin Zdzienicki; Katarzyna Kozak
Journal:  Melanoma Manag       Date:  2014-09-05

Review 3.  Surgery for Metastatic Melanoma: an Evolving Concept.

Authors:  Alessandro A E Testori; Stephanie A Blankenstein; Alexander C J van Akkooi
Journal:  Curr Oncol Rep       Date:  2019-11-06       Impact factor: 5.075

4.  Combined intralesional Bacille Calmette-Guérin (BCG) and topical imiquimod for in-transit melanoma.

Authors:  Travis B Kidner; Donald L Morton; Delphine J Lee; Mary Hoban; Leland J Foshag; Roderick R Turner; Mark B Faries
Journal:  J Immunother       Date:  2012 Nov-Dec       Impact factor: 4.456

5.  Isolated limb infusion in a series of over 100 infusions: a single-center experience.

Authors:  Joyce Wong; Y Ann Chen; Kate J Fisher; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2013-03-02       Impact factor: 5.344

6.  Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma.

Authors:  Joyce Wong; Y Ann Chen; Kate J Fisher; Georgia M Beasley; Douglas S Tyler; Jonathan S Zager
Journal:  Ann Surg Oncol       Date:  2013-10-26       Impact factor: 5.344

Review 7.  Developments in Intralesional Therapy for Metastatic Melanoma.

Authors:  Sarah Sloot; Omar M Rashid; Arnod A Sarnaik; Jonathan S Zager
Journal:  Cancer Control       Date:  2016-01       Impact factor: 3.302

Review 8.  In-transit metastatic cutaneous melanoma: current management and future directions.

Authors:  Ayushi Patel; Michael J Carr; James Sun; Jonathan S Zager
Journal:  Clin Exp Metastasis       Date:  2021-05-17       Impact factor: 5.150

9.  Malignant Skin Cancer Excision in Combined Therapy with Electro-Chemotherapy and Dermal Substitute.

Authors:  Barbara De Angelis; Alberto Balzani; Alessia Pagnotta; Eleonora Tati; Fabrizio Orlandi; Margarida Fernandes Lopes Morais D'Autilio; Valerio Cervelli; Pietro Gentile
Journal:  Curr Oncol       Date:  2021-05-05       Impact factor: 3.677

10.  Tumor size and effectiveness of electrochemotherapy.

Authors:  Barbara Mali; Damijan Miklavcic; Luca G Campana; Maja Cemazar; Gregor Sersa; Marko Snoj; Tomaz Jarm
Journal:  Radiol Oncol       Date:  2013-02-01       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.